Targeted dual degradation of GPC-3 and VEGFR with multivalent DNA nanoflower-based LYTACs for hepatocellular carcinoma therapy.

Zhou P, Zang J, Wang J, Cao M, Ge R, Liu Y, Pan W, Chen M, Liu H, Xuan C, Sun T, Xie S

DOI: 10.1016/j.jconrel.2026.115408
Published: 2026 Sep 23
Container: Journal of controlled release : official journal of the Controlled Release Society
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jconrel.2026.115408,
  title = {Targeted dual degradation of GPC-3 and VEGFR with multivalent DNA nanoflower-based LYTACs for hepatocellular carcinoma therapy.},
  author = {Zhou P and Zang J and Wang J and Cao M and Ge R and Liu Y and Pan W and Chen M and Liu H and Xuan C and Sun T and Xie S},
  year = {2026},
  journal = {Journal of controlled release : official journal of the Controlled Release Society},
  doi = {10.1016/j.jconrel.2026.115408},
  url = {https://doi.org/10.1016/j.jconrel.2026.115408}
}

RIS

TY  - JOUR
TI  - Targeted dual degradation of GPC-3 and VEGFR with multivalent DNA nanoflower-based LYTACs for hepatocellular carcinoma therapy.
AU  - Zhou P
AU  - Zang J
AU  - Wang J
AU  - Cao M
AU  - Ge R
AU  - Liu Y
AU  - Pan W
AU  - Chen M
AU  - Liu H
AU  - Xuan C
AU  - Sun T
AU  - Xie S
PY  - 2026
JO  - Journal of controlled release : official journal of the Controlled Release Society
DO  - 10.1016/j.jconrel.2026.115408
UR  - https://doi.org/10.1016/j.jconrel.2026.115408
ER  -

APA

P, Z., J, Z., J, W., M, C., R, G., Y, L., W, P., M, C., H, L., C, X., T, S., & S, X. (2026). Targeted dual degradation of GPC-3 and VEGFR with multivalent DNA nanoflower-based LYTACs for hepatocellular carcinoma therapy.. Journal of controlled release : official journal of the Controlled Release Society. https://doi.org/10.1016/j.jconrel.2026.115408

Source records

pubmed · retrieved 2026-09-25T03:32:27.561Z